Rebleeding Rates Following TIPS for Variceal Hemorrhage in the Viatorr Era: TIPS Alone Versus TIPS with Variceal Embolization

Overview

Journal Hepatol Int

Publisher Springer

Specialty Gastroenterology

Date 2011 Feb 3

PMID 21286346

Citations 18

Authors

Ron C Gaba

James T Bui

Scott J Cotler

Eric R Kallwitz

Olga T Mengin

Brandon K Martinez

Jaime L Berkes

Tami C Carrillo

M Grace Knuttinen

Charles A Owens

Affiliations

Soon will be listed here.

Abstract

Purpose: To compare rebleeding rates following treatment of variceal hemorrhage with TIPS alone versus TIPS with variceal embolization in the covered stent-graft era.

Methods: In this retrospective study, 52 patients (M:F 29:23, median age 52 years) with hepatic cirrhosis and variceal hemorrhage underwent TIPS insertion between 2003 and 2008. Median Child-Pugh and MELD scores were 8.5 and 13.5. Generally, 10-mm diameter TIPS were created using covered stent-grafts (Viatorr; W.L. Gore and Associates, Flagstaff, AZ). A total of 37 patients underwent TIPS alone, while 15 patients underwent TIPS with variceal embolization. The rates of rebleeding and survival were compared.

Results: All TIPS were technically successful. Median portosystemic pressure gradient reductions were 13 versus 11 mmHg in the embolization and non-embolization groups. There were no statistically significant differences in Child-Pugh and MELD score, or portosystemic pressure gradients between each group. A trend toward increased rebleeding was present in the non-embolization group, where 8/37 (21.6%) patients rebled while 1/15 (6.7%) patients in the TIPS with embolization group rebled (P = 0.159) during median follow-up periods of 199 and 252 days (P = 0.374). Rebleeding approached statistical significance among patients with acute hemorrhage, where 8/32 (25%) versus 0/14 (0%) rebled in the non-embolization and embolization groups (P = 0.055). A trend toward increased bleeding-related mortality was seen in the non-embolization group (P = 0.120).

Conclusions: TIPS alone showed a high incidence of rebleeding in this series, whereas TIPS with variceal embolization resulted in reduced recurrent hemorrhage. The efficacy of embolization during TIPS performed for variceal hemorrhage versus TIPS alone should be further compared with larger prospective randomized trials.

Citing Articles

Comparison of specialized stent versus generic stent and bare stent combination for transjugular intrahepatic portosystemic shunt creation.

Bai Y, Liu J, Wang C, Yao W, Ju S, Wang Y Sci Rep. 2024; 14(1):14439.

PMID: 38910214 PMC: 11194257. DOI: 10.1038/s41598-024-64358-0.

Afferent vein embolization via retrograde approach as a potential treatment strategy for bleeding duodenal varices.

Jogo A, Yamamoto A, Kageyama K, Sasaki F, Oura T, Mitsuyama Y Radiol Case Rep. 2023; 18(12):4327-4330.

PMID: 37789920 PMC: 10542599. DOI: 10.1016/j.radcr.2023.08.096.

Transjugular Intrahepatic Portosystemic Shunt With or Without Gastroesophageal Variceal Embolization for the Prevention of Variceal Rebleeding: A Systematic Review and Meta-Analysis.

Jaber F, Beran A, Alsakarneh S, Ahmed K, Abdallah M, Elfert K Gastroenterology Res. 2023; 16(2):68-78.

PMID: 37187555 PMC: 10181335. DOI: 10.14740/gr1618.

Comparative outcome of transjugular intrahepatic portosystemic shunt with or without variceal obliteration: a systematic review and meta-analysis.

Giri S, Patel R, Varghese J, Agarwal D, Tripathy T Abdom Radiol (NY). 2023; 48(4):1429-1437.

PMID: 36821005 DOI: 10.1007/s00261-023-03843-y.

[Current Interventional Management of Acute Upper Gastrointestinal Bleeding].

Yang L Sichuan Da Xue Xue Bao Yi Xue Ban. 2022; 53(3):361-366.

PMID: 35642139 PMC: 10409413. DOI: 10.12182/20220560206.

References

Ter Borg P, Hollemans M, van Buuren H, Vleggaar F, Groeneweg M, Hop W . Transjugular intrahepatic portosystemic shunts: long-term patency and clinical results in a patient cohort observed for 3-9 years. Radiology. 2004; 231(2):537-45. DOI: 10.1148/radiol.2312021797. View

Sahagun G, Benner K, Saxon R, Barton R, Rabkin J, Keller F . Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage. Am J Gastroenterol. 1997; 92(9):1444-52. View

Boyer T . Transjugular intrahepatic portosystemic shunt in the management of complications of portal hypertension. Curr Gastroenterol Rep. 2008; 10(1):30-5. DOI: 10.1007/s11894-008-0006-y. View

Charon J, Alaeddin F, Pimpalwar S, Fay D, Olliff S, Jackson R . Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol. 2004; 15(11):1219-30. DOI: 10.1097/01.RVI.0000137434.19522.E5. View

Kessler J, Trerotola S . Use of the Amplatzer Vascular Plug for embolization of a large retroperitoneal shunt during transjugular intrahepatic portosystemic shunt creation for gastric variceal bleeding. J Vasc Interv Radiol. 2006; 17(1):135-40. DOI: 10.1097/01.rvi.0000186958.59457.10. View

Burroughs A, Triantos C, OBeirne J, Patch D . Predictors of early rebleeding and mortality after acute variceal hemorrhage in patients with cirrhosis. Nat Clin Pract Gastroenterol Hepatol. 2008; 6(2):72-3. DOI: 10.1038/ncpgasthep1336. View

Berzigotti A, Garcia-Pagan J . Prevention of recurrent variceal bleeding. Dig Liver Dis. 2008; 40(5):337-42. DOI: 10.1016/j.dld.2007.12.003. View

Boyer T, Haskal Z . American Association for the Study of Liver Diseases Practice Guidelines: the role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension. J Vasc Interv Radiol. 2005; 16(5):615-29. DOI: 10.1097/01.RVI.0000157297.91510.21. View

Sanyal A, FREEDMAN A, Luketic V, Purdum 3rd P, Shiffman M, DeMeo J . The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology. 1997; 112(3):889-98. DOI: 10.1053/gast.1997.v112.pm9041251. View

10.

Tesdal I, Jaschke W, Buhler M, Adamus R, Filser T, Holm E . Transjugular intrahepatic portosystemic shunting (TIPS) with balloon-expandable and self-expanding stents: technical and clinical aspects after 3 1/2 years' experience. Cardiovasc Intervent Radiol. 1997; 20(1):29-37. DOI: 10.1007/s002709900105. View

11.

Martin M, Zajko A, Orons P, Dodd G, Wright H, Colangelo J . Transjugular intrahepatic portosystemic shunt in the management of variceal bleeding: indications and clinical results. Surgery. 1993; 114(4):719-26; discussion 726-7. View

12.

Angermayr B, Cejna M, Koenig F, Karnel F, Hackl F, Gangl A . Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents. Hepatology. 2003; 38(4):1043-50. DOI: 10.1053/jhep.2003.50423. View

13.

Maleux G, Nevens F, Wilmer A, Heye S, Verslype C, Thijs M . Early and long-term clinical and radiological follow-up results of expanded-polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures. Eur Radiol. 2004; 14(10):1842-50. DOI: 10.1007/s00330-004-2359-4. View

14.

Nazarian G, Ferral H, Bjarnason H, Foshager M, Rank J, Anderson C . Development of stenoses in transjugular intrahepatic portosystemic shunts. Radiology. 1994; 192(1):231-4. DOI: 10.1148/radiology.192.1.8208944. View

15.

Colombato L . The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension. J Clin Gastroenterol. 2007; 41 Suppl 3:S344-51. DOI: 10.1097/MCG.0b013e318157e500. View

16.

Laberge J, Somberg K, Lake J, Gordon R, Kerlan Jr R, Ascher N . Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology. 1995; 108(4):1143-51. DOI: 10.1016/0016-5085(95)90213-9. View

17.

Maruyama H, Yokosuka O . Current management of gastric varices. JNMA J Nepal Med Assoc. 2008; 46(167):143-50. View

18.

Hausegger K, Karnel F, Georgieva B, Tauss J, Portugaller H, Deutschmann H . Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft. J Vasc Interv Radiol. 2004; 15(3):239-48. DOI: 10.1097/01.rvi.0000116194.44877.c1. View

19.

Tripathi D, Ferguson J, Barkell H, MacBeth K, Ireland H, Redhead D . Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents. Eur J Gastroenterol Hepatol. 2006; 18(3):225-32. DOI: 10.1097/00042737-200603000-00001. View

20.

Haskal Z, Scott M, Rubin R, Cope C . Intestinal varices: treatment with the transjugular intrahepatic portosystemic shunt. Radiology. 1994; 191(1):183-7. DOI: 10.1148/radiology.191.1.8134568. View